Cargando…
Impact of the COVID-19 pandemic on the prescription of disease-modifying therapy for multiple sclerosis in England: a nationwide study
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BMJ Publishing Group
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9606541/ https://www.ncbi.nlm.nih.gov/pubmed/35273069 http://dx.doi.org/10.1136/jnnp-2021-328340 |
| _version_ | 1784818320867852288 |
|---|---|
| author | Williams, Thomas Mishra, Rhea Bharkhada, Brina Shields, Aoife Dorsey, Rachel Chataway, Jeremy Brownlee, Wallace J |
| author_facet | Williams, Thomas Mishra, Rhea Bharkhada, Brina Shields, Aoife Dorsey, Rachel Chataway, Jeremy Brownlee, Wallace J |
| author_sort | Williams, Thomas |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9606541 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | BMJ Publishing Group |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-96065412022-10-28 Impact of the COVID-19 pandemic on the prescription of disease-modifying therapy for multiple sclerosis in England: a nationwide study Williams, Thomas Mishra, Rhea Bharkhada, Brina Shields, Aoife Dorsey, Rachel Chataway, Jeremy Brownlee, Wallace J J Neurol Neurosurg Psychiatry PostScript BMJ Publishing Group 2022-11 2022-03-10 /pmc/articles/PMC9606541/ /pubmed/35273069 http://dx.doi.org/10.1136/jnnp-2021-328340 Text en © Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) . |
| spellingShingle | PostScript Williams, Thomas Mishra, Rhea Bharkhada, Brina Shields, Aoife Dorsey, Rachel Chataway, Jeremy Brownlee, Wallace J Impact of the COVID-19 pandemic on the prescription of disease-modifying therapy for multiple sclerosis in England: a nationwide study |
| title | Impact of the COVID-19 pandemic on the prescription of disease-modifying therapy for multiple sclerosis in England: a nationwide study |
| title_full | Impact of the COVID-19 pandemic on the prescription of disease-modifying therapy for multiple sclerosis in England: a nationwide study |
| title_fullStr | Impact of the COVID-19 pandemic on the prescription of disease-modifying therapy for multiple sclerosis in England: a nationwide study |
| title_full_unstemmed | Impact of the COVID-19 pandemic on the prescription of disease-modifying therapy for multiple sclerosis in England: a nationwide study |
| title_short | Impact of the COVID-19 pandemic on the prescription of disease-modifying therapy for multiple sclerosis in England: a nationwide study |
| title_sort | impact of the covid-19 pandemic on the prescription of disease-modifying therapy for multiple sclerosis in england: a nationwide study |
| topic | PostScript |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9606541/ https://www.ncbi.nlm.nih.gov/pubmed/35273069 http://dx.doi.org/10.1136/jnnp-2021-328340 |
| work_keys_str_mv | AT williamsthomas impactofthecovid19pandemicontheprescriptionofdiseasemodifyingtherapyformultiplesclerosisinenglandanationwidestudy AT mishrarhea impactofthecovid19pandemicontheprescriptionofdiseasemodifyingtherapyformultiplesclerosisinenglandanationwidestudy AT bharkhadabrina impactofthecovid19pandemicontheprescriptionofdiseasemodifyingtherapyformultiplesclerosisinenglandanationwidestudy AT shieldsaoife impactofthecovid19pandemicontheprescriptionofdiseasemodifyingtherapyformultiplesclerosisinenglandanationwidestudy AT dorseyrachel impactofthecovid19pandemicontheprescriptionofdiseasemodifyingtherapyformultiplesclerosisinenglandanationwidestudy AT chatawayjeremy impactofthecovid19pandemicontheprescriptionofdiseasemodifyingtherapyformultiplesclerosisinenglandanationwidestudy AT brownleewallacej impactofthecovid19pandemicontheprescriptionofdiseasemodifyingtherapyformultiplesclerosisinenglandanationwidestudy |